Y, Z., L, L., H, B., K, X., H, Z., S, W., . . . W, W. (2026). Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer. Molecular biomedicine, 7(1), . https://doi.org/10.1186/s43556-026-00497-2
Chicago Style (17th ed.) CitationY, Zhang, et al. "Integrative CfDNA Profiling from Low-pass Whole-genome Sequencing Enables Tissue-of-origin Prediction in Cancer." Molecular Biomedicine 7, no. 1 (2026). https://doi.org/10.1186/s43556-026-00497-2.
MLA (9th ed.) CitationY, Zhang, et al. "Integrative CfDNA Profiling from Low-pass Whole-genome Sequencing Enables Tissue-of-origin Prediction in Cancer." Molecular Biomedicine, vol. 7, no. 1, 2026, https://doi.org/10.1186/s43556-026-00497-2.
Warning: These citations may not always be 100% accurate.